BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38754467)

  • 1. Non-Small Cell Lung Cancer, Version 4.2024.
    Riely GJ; Wood DE; Ettinger DS; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; DeCamp M; Desai AP; Dilling TJ; Dowell J; Durm GA; Gettinger S; Grotz TE; Gubens MA; Juloori A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Mullikin TC; Ng T; Owen D; Owen DH; Patel SP; Patil T; Polanco PM; Riess J; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory KM; Hang L
    J Natl Compr Canc Netw; 2024 May; 22(4):249-274. PubMed ID: 38754467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; DeCamp M; Dilling TJ; Dowell J; Gettinger S; Grotz TE; Gubens MA; Hegde A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Ng T; Otterson GA; Pacheco JM; Patel SP; Riely GJ; Riess J; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2022 May; 20(5):497-530. PubMed ID: 35545176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman J; Chirieac LR; D'Amico TA; DeCamp MM; Dilling TJ; Dobelbower M; Doebele RC; Govindan R; Gubens MA; Hennon M; Horn L; Komaki R; Lackner RP; Lanuti M; Leal TA; Leisch LJ; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Stevenson J; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2017 Apr; 15(4):504-535. PubMed ID: 28404761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Horn L; Jahan TM; Jahanzeb M; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Lennes IT; Loo BW; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Swanson SJ; Wood DE; Yang SC; Hughes M; Gregory KM;
    J Natl Compr Canc Netw; 2012 Oct; 10(10):1236-71. PubMed ID: 23054877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; Dilling TJ; Dowell J; Gettinger S; Gubens MA; Hegde A; Hennon M; Lackner RP; Lanuti M; Leal TA; Lin J; Loo BW; Lovly CM; Martins RG; Massarelli E; Morgensztern D; Ng T; Otterson GA; Patel SP; Riely GJ; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Yanagawa J; Yang SC; Gregory KM; Hughes M
    J Natl Compr Canc Netw; 2021 Mar; 19(3):254-266. PubMed ID: 33668021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Therapy for Patients With Metastatic Non-Small Cell Lung Cancer.
    Reckamp KL
    J Natl Compr Canc Netw; 2018 May; 16(5S):601-604. PubMed ID: 29784736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study.
    Gridelli C; de Marinis F; Ardizzoni A; Novello S; Fontanini G; Cappuzzo F; Grossi F; Santo A; Cortinovis D; Favaretto A; Lorusso V; Galetta D; Siena S; Bettini A; Iurlaro M; Caprioli A;
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1783-93. PubMed ID: 24903964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Small Cell Lung Cancer, Version 6.2015.
    Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Dilling TJ; Dobelbower MC; Govindan R; Grannis FW; Horn L; Jahan TM; Komaki R; Krug LM; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Schild SE; Shapiro TA; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M;
    J Natl Compr Canc Netw; 2015 May; 13(5):515-24. PubMed ID: 25964637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-small cell lung cancer, version 1.2015.
    Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Dilling TJ; Govindan R; Grannis FW; Horn L; Jahan TM; Komaki R; Kris MG; Krug LM; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Schild S; Shapiro TA; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2014 Dec; 12(12):1738-61. PubMed ID: 25505215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
    Ettinger DS; Aisner DL; Wood DE; Akerley W; Bauman J; Chang JY; Chirieac LR; D'Amico TA; Dilling TJ; Dobelbower M; Govindan R; Gubens MA; Hennon M; Horn L; Lackner RP; Lanuti M; Leal TA; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel SP; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Stevenson J; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2018 Jul; 16(7):807-821. PubMed ID: 30006423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Hanna N; Johnson D; Temin S; Baker S; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB; Riely GJ; Schiller JH; Schneider BJ; Smith TJ; Tashbar J; Biermann WA; Masters G
    J Clin Oncol; 2017 Oct; 35(30):3484-3515. PubMed ID: 28806116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region.
    Jazieh AR; Bamefleh H; Demirkazik A; Gaafar RM; Geara FB; Javaid M; Khader J; Khodadad K; Omar W; Saadeddin A; Sabe HA; Shadmehr MB; El Sherif A; Uddin N; Jahanzeb M; Ettinger D;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S16-21. PubMed ID: 20697125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing of circulating tumor DNA for metastatic non-small cell lung cancer: a discussion on its implementation in the Brazilian clinical practice.
    H Araujo L; Ferreira CG; Baldotto CS; Mathias C; Castro G; Coudry R
    Future Oncol; 2021 Jan; 17(2):205-213. PubMed ID: 33052747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An estimate of rate of deviation from NCCN guideline recommendations for central nervous system imaging in trials forming basis for drug approval in first line advanced non-small cell lung cancer (NSCLC).
    Sharp J; Prasad V
    BMC Cancer; 2022 Jan; 22(1):70. PubMed ID: 35034621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.
    Kerr KM; Bubendorf L; Edelman MJ; Marchetti A; Mok T; Novello S; O'Byrne K; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Sep; 25(9):1681-1690. PubMed ID: 24718890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study.
    Charpidou A; Mani M; Kokkotou E; Stournara L; Stathelou L; Antoniadou K; Argyropoulos E; Syrigos KN
    Anticancer Res; 2024 May; 44(5):2063-2072. PubMed ID: 38677737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Peters S; Adjei AA; Gridelli C; Reck M; Kerr K; Felip E;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii56-64. PubMed ID: 22997455
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving Treatment Options for Lung Cancer.
    Morgensztern D; Herbst RS
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):xiii-xiv. PubMed ID: 27912837
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Bepler G; Blum MG; Chang A; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Jahan T; Jahanzeb M; Johnson DH; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Le QT; Lennes IT; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Simon GR; Swanson SJ; Wood DE; Yang SC;
    J Natl Compr Canc Netw; 2010 Jul; 8(7):740-801. PubMed ID: 20679538
    [No Abstract]   [Full Text] [Related]  

  • 20. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.
    Osmani L; Askin F; Gabrielson E; Li QK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):103-109. PubMed ID: 29183778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.